stopprofile

419 results found.

Top Stocks matching your search for "stop profile"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 23, 2023

“Statistically significant improvements in lung fu... See more

Dec, 3, 2022

Anavex said that the candidate's safety profil... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
BCRX

Biocryst Pharmaceuticals Inc.

-23.50%

$10.68 - $8.17

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 9, 2023

"We believe BCX10013 has the potential to be ... See more

Dec, 10, 2022

Safety profile is decent.

Image with triangles

Divihomes is Now Live

A new search platform that matches you with the best home improvement service providers in your area.

Instant Search & Match with Top Contractors

Instant Communication with Local Contractors

Phone Image with DiviHomes website

Millions of Unbiased User Reviews

100% Free Quotes from Top-Notch Contractors

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 23, 2023

“Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023” Oh, 48 weeks! !

Dec, 3, 2022

Anavex said that the candidate's safety profile also appeared to be relatively good.

Nov, 30, 2022

Anavex also better in ADAS-Cog14, and far superior safety profile.

Nov, 18, 2022

>> no clinically significant treatment-related adverse events and no serious adverse events = PERFECT SAFETY PROFILE !!

Nov, 14, 2022

$AVXL safety profile = excellent !!

Oct, 30, 2022

with Blarcamesine's outstanding safety profile this will become the #1 off label prescribed drug in the world.

Oct, 4, 2022

$AVXL for Hans, yes $avxl is great and will get approved when it’s high dose arm absolutely crushes the current SOC with a flawless safety profile.

BCRX

Biocryst Pharmaceuticals Inc.

-23.50%

$10.68 - $8.17

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 9, 2023

"We believe BCX10013 has the potential to be a best-in-class treatment option with an oral, once-daily profile,”

Dec, 10, 2022

Safety profile is decent.

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.